Claims Review to Be Enhanced for Oncology Drugs and Services for Government Programs, Effective June 1, 2025
Act
by Jun 1, 2025
Effective date
Jun 1, 2025
Identified
Jan 12, 2026
Summary
Effective June 1, 2025, enhanced claims review will be implemented for oncology drugs and associated services for Medicare Advantage and Medicaid members. Claims lacking appropriate procedure and diagnosis codes will face delays or denials, requiring strict adherence to standard coding guidelines including ICD-10, HCPCS, and CPT codes.
Get alerts when payers change rules like this one
We check BCBS Texas and other payers every day and email you when a change matches your specialty and state.
01Billing team must ensure all oncology drug claims for Medicare Advantage and Medicaid members include accurate procedure and diagnosis code combinations per ICD-10, HCPCS, and CPT guidelines.
02Review current oncology billing workflows and update staff training on proper coding requirements.
03Inaccurately coded claims will result in denied or delayed payment.
Original notice
Claims Review to Be Enhanced for Oncology Drugs and Services for Government Programs, Effective June 1, 2025
bcbstx.com · Always check the source before changing claims.
Summaries are AI-assisted. Always confirm against the original payer notice.
What is PolicyChanges
One workspace for payer rules, prior auth, coding and compliance
Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.